Jaguar Health (JAGX) FCF Margin (2015 - 2026)
Jaguar Health's (JAGX) quarterly FCF Margin came in at 43.74% in Q1 2026, up 37409.0% year-on-year from N/an in Q1 2025, and up 133.21% on a QoQ basis from 131.72% in Q4 2025.
Jaguar Health (JAGX) FCF Margin (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of FCF Margin data on file, last reported at 43.74% in Q1 2026.
- On a quarterly basis, FCF Margin rose 37409.0% year-over-year to 43.74% in Q1 2026; TTM through Mar 2026 was 21.77%, a 24140.0% increase from a year earlier, with the FY2025 full-year figure at 195.58%, up 5594.0% from the prior year.
- FCF Margin for Q1 2026 stood at 43.74%, up from 131.72% in the prior quarter.
- Over the last five years, FCF Margin for JAGX reached as high as 43.74% in Q1 2026 and fell as low as 38500.0% in Q1 2022.
- Historically, FCF Margin has averaged 4705.21% across 5 years, with a median of 278.97% in 2022.
- Across the five-year window, FCF Margin plunged 3794619 bps in 2022 and jumped 2187152 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 15953.12% in 2022, then jumped by 98 bps to 323.83% in 2023, then jumped by 34 bps to 214.05% in 2024, then jumped by 38 bps to 131.72% in 2025, then surged by 133 bps to 43.74% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 43.74% in Q1 2026, 131.72% in Q4 2025, and 157.28% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 10.45% |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 43.35% |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 23.53% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 4.17% |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 43.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.74% |
| Dec 31, 2025 | -131.72% |
| Sep 30, 2025 | -157.28% |
| Jun 30, 2025 | -207.96% |
| Mar 31, 2025 | -330.35% |
| Dec 31, 2024 | -214.05% |
| Sep 30, 2024 | -214.16% |
| Jun 30, 2024 | -327.86% |
| Mar 31, 2024 | -268.48% |
| Dec 31, 2023 | -323.83% |
| Sep 30, 2023 | -241.52% |
| Jun 30, 2023 | -344.65% |
| Mar 31, 2023 | -22,140.00% |
| Dec 31, 2022 | -15,953.13% |
| Sep 30, 2022 | -278.97% |
| Jun 30, 2022 | -398.36% |
| Mar 31, 2022 | -38,500.00% |
| Dec 31, 2021 | -431.06% |
| Sep 30, 2021 | -1,533.66% |
| Jun 30, 2021 | -2,608.97% |